2 completed, 2 terminated, 1 active not recruiting, 1 unknown. 4 Phase 2, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Active not recruiting 1, Completed 1, Terminated 1, Unknown 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Terminated 1 |
Follow Eosinophil Cationic Protein: new trials by email Literature Review of Eosinophil Cationic Protein trials Research Report on Eosinophil Cationic Protein
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Randomized Phase II Study to Compare the Potential Long-Lasting Positive Effect of Decidual Stromal Cells to the Best Available Treatment in Graft Versus Host Disease Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP), mTOR inhibitors (everolimus or sirolimus), vedolizumab, ruxolitinib., Decidual Stromal Cells - Graft Vs Host Disease | Phase 2 | Active not recruiting | University Health Network, Toronto | 50 | 2021-12-22 | 2025-06-22 |
| Decidua Stroma Cells for Steroid Resistent Acute Graft-versus-host Disease After Allo-HSCT Decidua Stroma Cells (DSC), Best available Treatment (BAT) - GVHD, Acute | Phase 2 | Terminated | Mats Remberger | 12 | 2021-12-01 | 2026-05-06 |
| Modification of Extracorporeal Photopheresis in Cutaneous T-cell Lymphoma or Chronic Graft-versus-host Disease ECP with 5-aminolevulinic acid - Cutaneous T-Cell Lymphoma, Unspecified, Chronic Graft Versus Host Disease in Skin | Phase 1 / Phase 2 | Completed | St. Olavs Hospital | 7 | 2017-09-20 | 2023-01-13 |
| Extracorporeal Photopheresis in Children and Young Adults With Refractory Acute Graft Versus Host Disease ECP (performed on Themos UVAR-XTS or external UVA irradiator after cell collection by apheresis) - Graft Versus Host Disease | Phase 2 | Unknown | University Hospital, Clermont-Ferrand | 30 | 2009-06-01 | 2011-01-19 |
| Extracorporeal Photoimmune Therapy With UVADEX for the Treatment of Acute Graft Versus-Host Disease Methoxsalen+ECP, Methylprednisolone, Ecp - Acute Graft-versus-Host Disease | Phase 3 | Terminated | Mallinckrodt | 19 | 2006-01-01 | 2017-08-16 |
| Behçet's Disease and Eosinophil Cationic Protein eosinophil cationic protein - Behçet's Disease | Completed | Cukurova University | 47 | 2002-01-01 | 2012-04-26 |
Graft vs Host Disease (3) · Behcet Syndrome (1) · Lymphoma, T-Cell, Cutaneous (1)
Cukurova University (1) · Mallinckrodt (1) · Mats Remberger (1) · St. Olavs Hospital (1) · University Health Network, Toronto (1) · University Hospital, Clermont-Ferrand (1)
Canada (2) · France (2) · Norway (2) · Australia (1) · Austria (1) · Belgium (1) · Denmark (1) · Germany (1) · Italy (1) · Netherlands (1) · Sweden (1) · Switzerland (1) · Turkey (Türkiye) (1) · United Kingdom (1) · United States (1)
Eren Erken, Prof. Dr. (1) · Etienne Merlin (1) · Mats Remberger, Professor (1) · Vigleik Jessen, md (1)
2016 (1), 2019 (1)